Former Biotech CEO Plans to Find Cure For Alzheimer’s and ALS

December 16, 2014 4:09 PM

16 0

On Monday, Tony Coles, former CEO of Onyx Pharmaceuticals, announced the launch of a new biotech company that will use all its brain power and logistics in finding revolutionary yeast-based cures to Parkinson’s, Alzheimer’s and ALS disease. The technology used was developed by researcher Susan Lindquist who won the National Medal of Science for her brain-related research.

Mr Coles will use the money he got by selling Onyx to Amgen in 2013 to start Yumanity Therapeutics. The new start-up is headquartered in Cambridge, Massachusetts and will use yeast cells to find new treatment to several neurodegenerative diseases such as Parkinson’s and Alzheimer’s.

Read more

To category page